chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Oropharyngeal pain, Urine output increased
Clinical narrative: started getting sick; headache; muscle pain; joint pain; chills; throat is hurting bad; eyes hurt; urinating a lot; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (started getting sick), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain) and CHILLS (chills) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Blood pressure (High Blood Pressure) since an unknown date and Acid reflux (oesophageal) since an unknown date. Concurrent medical conditions included Drug allergy (Codeine allergy), Paracetamol (Tylenol allergy), Drug allergy (Morphine allergy) and Drug allergy (Statins Allergy). Concomitant products included OMEPRAZOLE (OMEPRAZOLE ACID REDUCER) and MELOXICAM for an unknown indication.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, the patient experienced MALAISE (started getting sick), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), OROPHARYNGEAL PAIN (throat is hurting bad), EYE PAIN (eyes hurt) and URINE OUTPUT INCREASED (urinating a lot). At the time of the report, MALAISE (started getting sick), HEADACHE (headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills), OROPHARYNGEAL PAIN (throat is hurting bad), EYE PAIN (eyes hurt) and URINE OUTPUT INCREASED (urinating a lot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products included blood pressure pills. The patients treatment information included Sumatriptan.
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction
Clinical narrative: delayed reaction at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (delayed reaction at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No relevant medical history reported).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE REACTION (delayed reaction at the injection site). At the time of the report, INJECTION SITE REACTION (delayed reaction at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Reporter states that her friend is a nurse and had the same delayed reaction at the injection site as her and states that it's a delayed immune response to the vaccine.
Sex: F
Vaccine: COVID19
Symptoms: Rash papular
Clinical narrative: Bilateral papular rash on hands and feet; This spontaneous case was reported by a physician and describes the occurrence of RASH PAPULAR (Bilateral papular rash on hands and feet) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH PAPULAR (Bilateral papular rash on hands and feet). At the time of the report, RASH PAPULAR (Bilateral papular rash on hands and feet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported  No treatment information was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Somnolence
Clinical narrative: sore arm; sleepy; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (sore arm) and SOMNOLENCE (sleepy) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and SOMNOLENCE (sleepy). On 29-Jan-2021, PAIN IN EXTREMITY (sore arm) and SOMNOLENCE (sleepy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment reported.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: Red sore arm; Red sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Red sore arm) and ERYTHEMA (Red sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Red sore arm) and ERYTHEMA (Red sore arm). At the time of the report, PAIN IN EXTREMITY (Red sore arm) and ERYTHEMA (Red sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Sore arm; Tired for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired for a couple of days) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No relevant medical history was reported.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) and IBANDRONATE SODIUM (BONIVA) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired for a couple of days). At the time of the report, PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired for a couple of days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Redness a few inches below the injection site and there was hardness; Redness a few inches below the injection site and there was itching; Redness a few inches below the injection site; Tenderness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (Redness a few inches below the injection site and there was hardness), VACCINATION SITE PRURITUS (Redness a few inches below the injection site and there was itching), VACCINATION SITE ERYTHEMA (Redness a few inches below the injection site) and VACCINATION SITE PAIN (Tenderness at injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) and VITAMINS NOS for an unknown indication.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PAIN (Tenderness at injection site). On 25-Jan-2021, the patient experienced VACCINATION SITE INDURATION (Redness a few inches below the injection site and there was hardness), VACCINATION SITE PRURITUS (Redness a few inches below the injection site and there was itching) and VACCINATION SITE ERYTHEMA (Redness a few inches below the injection site). The patient was treated with ARNICA MONTANA, CALENDULA OFFICINALIS (ARNICA COMP) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INDURATION (Redness a few inches below the injection site and there was hardness), VACCINATION SITE PRURITUS (Redness a few inches below the injection site and there was itching) and VACCINATION SITE PAIN (Tenderness at injection site) had resolved and VACCINATION SITE ERYTHEMA (Redness a few inches below the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient applied Arnica Gel on the site. Patient did not give consent for Safety to contact them.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Vitreous floaters
Clinical narrative: Floater in eye; This spontaneous case was reported by a consumer and describes the occurrence of VITREOUS FLOATERS (Floater in eye) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history was not reported .  Concomitant products included LEVOTHYROXINE and AMLODIPINE BESILATE, BENAZEPRIL HYDROCHLORIDE (AMLODIPINE AND BENAZEPRIL HYDROCHLORIDE) for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jan-2021, the patient experienced VITREOUS FLOATERS (Floater in eye). At the time of the report, VITREOUS FLOATERS (Floater in eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dry mouth, Feeling abnormal, Feeling of body temperature change
Clinical narrative: Severe migraines; Hot and cold; Fell asleep on the phone; Her whole body went numb; Zombie kind of feeling; Diarrhea; Dry mouth; It feels like the flu; Wanting to throw up; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Severe migraines), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), SLEEP DISORDER (Fell asleep on the phone), HYPOAESTHESIA (Her whole body went numb) and FEELING ABNORMAL (Zombie kind of feeling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid cancer in 2017.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced MIGRAINE (Severe migraines), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), SLEEP DISORDER (Fell asleep on the phone), HYPOAESTHESIA (Her whole body went numb), FEELING ABNORMAL (Zombie kind of feeling), DIARRHOEA (Diarrhea), DRY MOUTH (Dry mouth), INFLUENZA LIKE ILLNESS (It feels like the flu), NAUSEA (Wanting to throw up) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MIGRAINE (Severe migraines), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), SLEEP DISORDER (Fell asleep on the phone), HYPOAESTHESIA (Her whole body went numb), FEELING ABNORMAL (Zombie kind of feeling), DIARRHOEA (Diarrhea), DRY MOUTH (Dry mouth), INFLUENZA LIKE ILLNESS (It feels like the flu), NAUSEA (Wanting to throw up) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications used are Cancer medication.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Influenza like illness, Migraine, Nausea, Sleep disorder
Clinical narrative: Severe migraines; Hot and cold; Fell asleep on the phone; Her whole body went numb; Zombie kind of feeling; Diarrhea; Dry mouth; It feels like the flu; Wanting to throw up; Chills; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Severe migraines), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), SLEEP DISORDER (Fell asleep on the phone), HYPOAESTHESIA (Her whole body went numb) and FEELING ABNORMAL (Zombie kind of feeling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Thyroid cancer in 2017.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced MIGRAINE (Severe migraines), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), SLEEP DISORDER (Fell asleep on the phone), HYPOAESTHESIA (Her whole body went numb), FEELING ABNORMAL (Zombie kind of feeling), DIARRHOEA (Diarrhea), DRY MOUTH (Dry mouth), INFLUENZA LIKE ILLNESS (It feels like the flu), NAUSEA (Wanting to throw up) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, MIGRAINE (Severe migraines), FEELING OF BODY TEMPERATURE CHANGE (Hot and cold), SLEEP DISORDER (Fell asleep on the phone), HYPOAESTHESIA (Her whole body went numb), FEELING ABNORMAL (Zombie kind of feeling), DIARRHOEA (Diarrhea), DRY MOUTH (Dry mouth), INFLUENZA LIKE ILLNESS (It feels like the flu), NAUSEA (Wanting to throw up) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications used are Cancer medication.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Pain, Pyrexia
Clinical narrative: his body was aching; a low grade fever of 100.3F; the chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (his body was aching), PYREXIA (a low grade fever of 100.3F) and CHILLS (the chills) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for an unknown indication.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (his body was aching), PYREXIA (a low grade fever of 100.3F) and CHILLS (the chills). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, PAIN (his body was aching), PYREXIA (a low grade fever of 100.3F) and CHILLS (the chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, Body temperature: 100.3f (Inconclusive) low grade fever of 100.3F.         No Concomitant medications were provided
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Pain, Palpitations
Clinical narrative: Hand aching; Fatigue; Headache lasted for 12 hours; Joints and wrists started aching; Heart beat started racing over 90-100 for more than 24 hours; Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse; This spontaneous case was reported by a pharmacist and describes the occurrence of PALPITATIONS (Heart beat started racing over 90-100 for more than 24 hours), PRURITUS (Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse), PAIN (Hand aching), FATIGUE (Fatigue) and HEADACHE (Headache lasted for 12 hours) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID] and ZINC for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2001, the patient experienced PRURITUS (Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse). On 05-Jan-2021, the patient experienced PALPITATIONS (Heart beat started racing over 90-100 for more than 24 hours), PAIN (Hand aching), FATIGUE (Fatigue), HEADACHE (Headache lasted for 12 hours) and ARTHRALGIA (Joints and wrists started aching). On 06-Jan-2021, HEADACHE (Headache lasted for 12 hours) had resolved. At the time of the report, PALPITATIONS (Heart beat started racing over 90-100 for more than 24 hours), PRURITUS (Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse), PAIN (Hand aching), FATIGUE (Fatigue) and ARTHRALGIA (Joints and wrists started aching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter reported that the treatment antihistamine helped with itching. Treatment for the event included acetaminophen, fexofenadine, famotidine and antihistamine.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Hand aching; Fatigue; Headache lasted for 12 hours; Joints and wrists started aching; Heart beat started racing over 90-100 for more than 24 hours; Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse; This spontaneous case was reported by a pharmacist and describes the occurrence of PALPITATIONS (Heart beat started racing over 90-100 for more than 24 hours), PRURITUS (Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse), PAIN (Hand aching), FATIGUE (Fatigue) and HEADACHE (Headache lasted for 12 hours) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included VITAMIN D [VITAMIN D NOS], VITAMIN C [ASCORBIC ACID] and ZINC for an unknown indication.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2001, the patient experienced PRURITUS (Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse). On 05-Jan-2021, the patient experienced PALPITATIONS (Heart beat started racing over 90-100 for more than 24 hours), PAIN (Hand aching), FATIGUE (Fatigue), HEADACHE (Headache lasted for 12 hours) and ARTHRALGIA (Joints and wrists started aching). On 06-Jan-2021, HEADACHE (Headache lasted for 12 hours) had resolved. At the time of the report, PALPITATIONS (Heart beat started racing over 90-100 for more than 24 hours), PRURITUS (Joints, wrist, and face started itching/itching in same place I was achy, progressively getting worse), PAIN (Hand aching), FATIGUE (Fatigue) and ARTHRALGIA (Joints and wrists started aching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter reported that the treatment antihistamine helped with itching. Treatment for the event included acetaminophen, fexofenadine, famotidine and antihistamine.
Sex: F
Vaccine: COVID19
Symptoms: Pharyngeal swelling
Clinical narrative: swelling on her throat; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (swelling on her throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 28-Jan-2021, the patient experienced PHARYNGEAL SWELLING (swelling on her throat). At the time of the report, PHARYNGEAL SWELLING (swelling on her throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Reporter did not allow further contact
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Dyspnoea, Feeling hot, Headache, Hot flush
Clinical narrative: Second hot reaction on the left side of her face; Very sore arm like never before; Headache; Hot flash in the entire body lasted 5 seconds; Had to make myself breath; Sleep apnea; Felt hot in the face and cheeks; Anxiety; Trouble sleeping; This spontaneous case was reported by a nurse and describes the occurrence of HOT FLUSH (Hot flash in the entire body lasted 5 seconds), PAIN IN EXTREMITY (Very sore arm like never before), DYSPNOEA (Had to make myself breath), SLEEP APNOEA SYNDROME (Sleep apnea) and FEELING HOT (Felt hot in the face and cheeks) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Exercise induced asthma and Sleep apnea.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HOT FLUSH (Hot flash in the entire body lasted 5 seconds), PAIN IN EXTREMITY (Very sore arm like never before), DYSPNOEA (Had to make myself breath), SLEEP APNOEA SYNDROME (Sleep apnea), FEELING HOT (Felt hot in the face and cheeks) and HEADACHE (Headache). On 08-Jan-2021, the patient experienced FEELING HOT (Second hot reaction on the left side of her face). In January 2021, the patient experienced INSOMNIA (Trouble sleeping) and ANXIETY (Anxiety). On 06-Jan-2021, HOT FLUSH (Hot flash in the entire body lasted 5 seconds), DYSPNOEA (Had to make myself breath), SLEEP APNOEA SYNDROME (Sleep apnea) and FEELING HOT (Felt hot in the face and cheeks) had resolved. On 07-Jan-2021, PAIN IN EXTREMITY (Very sore arm like never before) had resolved. On 08-Jan-2021, FEELING HOT (Second hot reaction on the left side of her face) and HEADACHE (Headache) had resolved. At the time of the report, INSOMNIA (Trouble sleeping) and ANXIETY (Anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by reporter. Treatment for the event of trouble sleeping was antihistamine NOS.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Sleep apnoea syndrome, Vaccination site pain
Clinical narrative: Second hot reaction on the left side of her face; Very sore arm like never before; Headache; Hot flash in the entire body lasted 5 seconds; Had to make myself breath; Sleep apnea; Felt hot in the face and cheeks; Anxiety; Trouble sleeping; This spontaneous case was reported by a nurse and describes the occurrence of HOT FLUSH (Hot flash in the entire body lasted 5 seconds), PAIN IN EXTREMITY (Very sore arm like never before), DYSPNOEA (Had to make myself breath), SLEEP APNOEA SYNDROME (Sleep apnea) and FEELING HOT (Felt hot in the face and cheeks) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Exercise induced asthma and Sleep apnea.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HOT FLUSH (Hot flash in the entire body lasted 5 seconds), PAIN IN EXTREMITY (Very sore arm like never before), DYSPNOEA (Had to make myself breath), SLEEP APNOEA SYNDROME (Sleep apnea), FEELING HOT (Felt hot in the face and cheeks) and HEADACHE (Headache). On 08-Jan-2021, the patient experienced FEELING HOT (Second hot reaction on the left side of her face). In January 2021, the patient experienced INSOMNIA (Trouble sleeping) and ANXIETY (Anxiety). On 06-Jan-2021, HOT FLUSH (Hot flash in the entire body lasted 5 seconds), DYSPNOEA (Had to make myself breath), SLEEP APNOEA SYNDROME (Sleep apnea) and FEELING HOT (Felt hot in the face and cheeks) had resolved. On 07-Jan-2021, PAIN IN EXTREMITY (Very sore arm like never before) had resolved. On 08-Jan-2021, FEELING HOT (Second hot reaction on the left side of her face) and HEADACHE (Headache) had resolved. At the time of the report, INSOMNIA (Trouble sleeping) and ANXIETY (Anxiety) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by reporter. Treatment for the event of trouble sleeping was antihistamine NOS.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site warmth
Clinical narrative: warmness at the injection site; bad headache; A spontaneous report was received from a consumer concerning a 63-year-old, female patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed head ache and injection site warmth..   The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, included Fluticasone,Escitalopram, Atorvastatin  On 21 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot 013L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 28 Jan 2021, the patient developed headache.  On 29 Jan 2021, the patient developed injection site warmth.  Treatment for the event included, Butalbital..   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, Headache, was considered recovered on 28 Jan 2021. The outcome of the event, injection site warmth , was considered as unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Great big round red spot the size of her fist; Itching at injection site; Soreness at the injection site; Firmness at the injection site; A spontaneous report was received from a consumer, concerning a female patient of 79 Years, who received Moderna's COVID-19 vaccine and experienced Soreness at the injection site,Firmness at the injection site, Itching at injection site,Great big round red spot the size of her fist.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On 15 Jan 2021 , prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (Batch number 011J20A) via intramuscularly in her left arm for COVID-19 infection prophylaxis. On 24 Jan 2021, the patient experienced itching at injection site and on 25 Jan 2021 the patient reported a great big round red spot the size of her fist.  The patient was treated with warm compress and a calming cream.   Action taken with mRNA-1273 in response to the event was unknown.   The outcome of the event was  considered to be not resolved at the time of this report.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash in his left arm and then spread throughout the body; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash in his left arm and then spread throughout the body) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.  On 25-Jan-2021, after receiving second dose of  mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH (rash in his left arm and then spread throughout the body). At the time of the report, RASH (rash in his left arm and then spread throughout the body) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Arm was itching; Arm was swollen; Arm was red; Warm to touch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Arm was itching), VACCINATION SITE OEDEMA (Arm was swollen), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE WARMTH (Warm to touch) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy ti PEG.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Arm was itching), VACCINATION SITE OEDEMA (Arm was swollen), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE WARMTH (Warm to touch). On 23-Jan-2021, VACCINATION SITE PRURITUS (Arm was itching), VACCINATION SITE OEDEMA (Arm was swollen), VACCINATION SITE ERYTHEMA (Arm was red) and VACCINATION SITE WARMTH (Warm to touch) had resolved.   On Sunday 24Jan2021 she took Tylenol, Benadryl, and Cortisone and the side effects went away.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.  She wanted to know wheather she can take the second dose.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Eyelid irritation, Headache, Hypoaesthesia, Tremor
Clinical narrative: headache; developed on left side of their face, on the temple area of their forehead, there's been a numb; eyelid felt really heavy, like weigthed down; extremely shaky (arms, shoulders, hands); This spontaneous case was reported by a consumer and describes the occurrence of NERVOUS SYSTEM DISORDER (neurological issue), TREMOR (extremely shaky (arms, shoulders, hands)), HYPOAESTHESIA (developed on left side of their face, on the temple area of their forehead, there's been a numb), EYELID IRRITATION (eyelid felt really heavy, like weigthed down) and HEADACHE (headache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No historical condition were reported.). Concomitant products included PRAVASTATIN, Botox injections and Prolia vaccine.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced TREMOR (extremely shaky (arms, shoulders, hands)). On 24-Jan-2021, the patient experienced NERVOUS SYSTEM DISORDER (neurological issue), HYPOAESTHESIA (developed on left side of their face, on the temple area of their forehead, there's been a numb) and EYELID IRRITATION (eyelid felt really heavy, like weigthed down). On an unknown date, the patient experienced HEADACHE (headache). On 08-Jan-2021, TREMOR (extremely shaky (arms, shoulders, hands)) had resolved. At the time of the report, NERVOUS SYSTEM DISORDER (neurological issue), HYPOAESTHESIA (developed on left side of their face, on the temple area of their forehead, there's been a numb), EYELID IRRITATION (eyelid felt really heavy, like weigthed down) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included,tylenol   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Mass, Pain
Clinical narrative: Pain on the left side; Lump; Painful to eat; A spontaneous case was received from the consumer concerning female patient of unknown age who received Moderna's COVID-19 vaccine and experienced pain on the left side, lump and painful to eat.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26-Jan-2021 prior to the onset of the events, the patient received first of the two planned doses of mRNA-1273 for the prophylaxis of COVID-19 infection.  On 27-Jan-2021 the patient experienced she had pain on the left side from her neck, mouth, and ear. She felt like there was a lump. It has been very painful to eat. Treatment of the event was not provided.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome of the events, pain on the left side, lump and painful to eat was not resolved.
Age: 95.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: injection site a little swollen; itchiness at injection; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (injection site a little swollen), INJECTION SITE PRURITUS (itchiness at injection) and INJECTION SITE ERYTHEMA (redness at injection site) in a 95-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for an unknown indication.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Jan-2021, the patient experienced INJECTION SITE SWELLING (injection site a little swollen), INJECTION SITE PRURITUS (itchiness at injection) and INJECTION SITE ERYTHEMA (redness at injection site).   outcome was unknown and not Provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Rash at in injection site; Pain (at injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash at in injection site) and VACCINATION SITE PAIN (Pain (at injection site)) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE RASH (Rash at in injection site) and VACCINATION SITE PAIN (Pain (at injection site)). At the time of the report, VACCINATION SITE RASH (Rash at in injection site) and VACCINATION SITE PAIN (Pain (at injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pruritus, Vaccination site induration, Vaccination site pain, Vaccination site swelling
Clinical narrative: arm was sore, swollen, very itchy, hard, and hot to the touch; pain between her shoulder blades on her left side; arm was sore, swollen, very itchy, hard, and hot to the touch; arm was sore; arm was sore, swollen, very itchy, hard, and hot to the touch; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE INDURATION (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE PAIN (arm was sore), VACCINATION SITE SWELLING (arm was sore, swollen, very itchy, hard, and hot to the touch) and ARTHRALGIA (pain between her shoulder blades on her left side) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 37020A(?)) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE SWELLING (arm was sore, swollen, very itchy, hard, and hot to the touch). On 28-Jan-2021, the patient experienced VACCINATION SITE INDURATION (arm was sore, swollen, very itchy, hard, and hot to the touch). On an unknown date, the patient experienced PRURITUS (arm was sore, swollen, very itchy, hard, and hot to the touch) and ARTHRALGIA (pain between her shoulder blades on her left side). At the time of the report, PRURITUS (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE INDURATION (arm was sore, swollen, very itchy, hard, and hot to the touch), VACCINATION SITE PAIN (arm was sore) and VACCINATION SITE SWELLING (arm was sore, swollen, very itchy, hard, and hot to the touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Itchiness redness a rash in her arm near the injection site; Itchiness redness a rash in her arm near the injection site; Itchiness redness a rash in her arm near the injection site; Soreness on her arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness on her arm), VACCINATION SITE PRURITUS (Itchiness redness a rash in her arm near the injection site), VACCINATION SITE ERYTHEMA (Itchiness redness a rash in her arm near the injection site) and VACCINATION SITE RASH (Itchiness redness a rash in her arm near the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042l20a) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness on her arm). On 28-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness redness a rash in her arm near the injection site), VACCINATION SITE ERYTHEMA (Itchiness redness a rash in her arm near the injection site) and VACCINATION SITE RASH (Itchiness redness a rash in her arm near the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. On 22-Jan-2021, VACCINATION SITE PAIN (Soreness on her arm) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itchiness redness a rash in her arm near the injection site), VACCINATION SITE ERYTHEMA (Itchiness redness a rash in her arm near the injection site) and VACCINATION SITE RASH (Itchiness redness a rash in her arm near the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Neck pain, Pyrexia
Clinical narrative: back pain; neck pain; temporary fever (24 hours); chills (48 hours); This spontaneous case was reported by a non-health professional and describes the occurrence of   in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Itching at the injection site; This spontaneous case was reported by a patient and describes the occurrence of   in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for an unknown indication.     No Medical History information was reported.    On 16-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were provided. Treatment medications include Benadryl..   Reporter did not allow further contact
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Injection site pruritus, Rash
Clinical narrative: Itchiness at the injection site; Rash under left arm pit area; Felt light headed; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Felt light headed), INJECTION SITE PRURITUS (Itchiness at the injection site) and RASH (Rash under left arm pit area) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DIZZINESS (Felt light headed). On an unknown date, the patient experienced INJECTION SITE PRURITUS (Itchiness at the injection site) and RASH (Rash under left arm pit area). At the time of the report, DIZZINESS (Felt light headed), INJECTION SITE PRURITUS (Itchiness at the injection site) and RASH (Rash under left arm pit area) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pyrexia (fever), headache and fatigue in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 029L20A) for COVID-19 immunization. No medical history reported. On Jan 25, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced pyrexia (fever), headache and fatigue. At the time of the report, pyrexia (fever), headache and fatigue outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant medication and treatment information not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warm to touch; itching; red; sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (sore) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (sore). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) on 27-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency; HYDROCORTISONE on 27-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) on 27-Jan-2021 for Adverse event following immunisation, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PRURITUS (itching), VACCINATION SITE ERYTHEMA (red) and VACCINATION SITE PAIN (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site itchy; Injection site a little swollen; 3 inch red area around the injection site; Soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in her arm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Injection site a little swollen) and VACCINATION SITE ERYTHEMA (3 inch red area around the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arrhythmia (NOS). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Soreness in her arm). On 25-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Injection site a little swollen) and VACCINATION SITE ERYTHEMA (3 inch red area around the injection site). At the time of the report, PAIN IN EXTREMITY (Soreness in her arm), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE SWELLING (Injection site a little swollen) and VACCINATION SITE ERYTHEMA (3 inch red area around the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Additional concomitant product used include blood thinner NOS and medicine for her arritmia (arrhythmia). Soreness in her arm lasted 3-4 days. No treatment medications were reported.